Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,657 | 11,277 | 82,031 | 41,739 | 64,886 |
| Marketable Securities | 64,421 | 73,837 | 20,161 | 72,416 | 71,648 |
| Receivables | 22,216 | 22,007 | 22,180 | 20,042 | 16,837 |
| Other current assets | 10,558 | 11,537 | 9,260 | 14,356 | 16,419 |
| TOTAL | $102,852 | $118,658 | $133,632 | $148,553 | $169,790 |
| Non-Current Assets | |||||
| PPE Net | 1,396 | 1,581 | 1,655 | 1,775 | 1,693 |
| Intangibles | 10,606 | 10,909 | 10,912 | 10,934 | 10,094 |
| Other Non-Current Assets | 269 | 294 | 591 | 3,971 | 3,721 |
| TOTAL | $12,271 | $12,784 | $13,158 | $16,680 | $15,508 |
| Total Assets | $115,123 | $131,442 | $146,790 | $165,233 | $185,298 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,367 | 13,356 | 16,993 | 14,311 | 18,812 |
| Other current liabilities | N/A | 168 | 301 | 457 | 392 |
| TOTAL | $10,460 | $13,613 | $17,379 | $14,768 | $19,264 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 55,218 | 55,454 | 55,348 | 56,310 | 53,291 |
| TOTAL | $55,261 | $55,525 | $55,348 | $56,310 | $53,291 |
| Total Liabilities | $65,721 | $69,138 | $72,727 | $71,078 | $72,555 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 47,234 | 47,234 | 141,702 | 141,691 |
| Common Shares | -10,290 | -10,290 | 10,290 | 10,290 | 10,289 |
| Retained earnings | 577,526 | 562,572 | -550,802 | -529,844 | -502,536 |
| Other shareholders' equity | 102,172 | 127,584 | -3,073 | -1,404 | -8,084 |
| TOTAL | $49,402 | $62,304 | $74,063 | $94,155 | $112,743 |
| Total Liabilities And Equity | $115,123 | $131,442 | $146,790 | $165,233 | $185,298 |